B. Riley raised the firm’s price target on Mirion (MIR) to $22 from $17 and keeps a Buy rating on the shares ahead of the Q2 report on July 31. Due to alleviated tariff concerns and elevated expectations, Mirion’s Q2 report needs to meet consensus estimates to support the stock, the analyst tells investors in a research note. The firm believes the company is well positioned to benefit from the Trump administration’s executive orders to accelerate the approval of nuclear reactors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIR:
